Rezultati pretraživanja
  1. 6. pro 2019.

    What a great end of an excellent meeting by receiving the MND Clinical Poster prize for optimizing the use of the ALSFRS-R! The time may have come to say goodbye to the total score and make better use of its domain information in clinical trials.

  2. With the Symposium beginning tomorrow in Perth, we thought we'd ask Professor , who is attending, his thoughts on the importance of the event and what he's looking forward to most. Visit 🔬 to stay updated with the latest research!

  3. this is easily my favorite part of this year’s topic was ADVANCING INNOVATION IN ALS: THE IMPORTANCE OF ENVIRONMENT VS GENES IN THE DEVELOPMENT OF ALS click the link below to see the conversation and you…

  4. 4. pro 2019.

    Walk to D’Feet MND in Perth

  5. 5. pro 2019.

    We have tools to assess cognitive & behavioural changes in MND but how well are we able to support management? describes the development of the MiND Toolkit which aims to support clinicians, family & carers structure decision-making and management 👍🏻

  6. Ugly. The list of failed therapies trialed for ALS/MMD (with 2 minor exceptions). We clearly need better understanding of disease biology and better pre-clinical models.

    Prikaži ovu nit
  7. 1. pro 2019.

    A tiny teaser of some of the posters will be presenting this week at 2019 🤓

  8. 5. pro 2019.

    Metabolic rewireing in a fly model of ; TDP43 drosophila model with metabolic deficits. Increased capacity for neuronal glucose uptake with positive treatment effects following high glucose treatment...

  9. 3. pro 2019.

    The Biomarker Challenge: Martin Turner explains why we need new mechanistic biomarkers for ALS and how much progress has been made in the last 10 years

  10. 2. pro 2019.

    Interesting presentation from the Perron Institute in Perth looking at improving percentage of people with MND eligible for clinical trials. Geography a big issue in Western Australia 🇦🇺 but also recommendations about good respiratory monitoring. 👍🏼

  11. 5. pro 2019.

    Hande Ozdinier taking the immunity & inflammation session to great heights with very impressive data and beautiful imaging on neuroimmune modulation in the motor cortex with ALS MND TDP-43 pathology

  12. 2. pro 2019.

    None of this would be possible without our fantastic volunteers from and A huge thank you to them 👍🏼👏🏼👏🏼👏🏼🥵

  13. 4. pro 2019.

    From session to session! Thank you for a great meeting so far

  14. 5. pro 2019.

    Big ideas in tiny packages- nanoparticles to treat neuroinflammation MND! Taken up by immune cells? Amanda Wright using the TDP model of ALS MND to investigate plus ID'd genes unregulated before neuron loss begins

  15. It’s a long way to go, but I am looking forward to presenting at the in Perth this weekend, highlighting ’s collaborations with , , & this past year. This community works better together.

  16. Thank you to for supporting WiFi at in Perth. Log on. Donate today!

  17. 3. pro 2019.

    ALS a disease of the human brain - cortical change and spread of mirrors the focal clinical onset and disease progression

  18. 3. pro 2019.

    2019 in Perth. So proud that we are part of this important conference where all focus to

  19. 26. stu 2019.

    Today we announced five presentations at the upcoming International Symposium on ALS/MND in Perth, Australia

  20. 5. pro 2019.

    Dr. Richard Robitaille officially invites attendees to Montreal2020!

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.